T14.SI Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 12:04):

Stats
Šios dienos apimtis	389 300
Vidutinė apimtis	150 347
Rinkos kapitalizacija	4.07B
EPS	$0 ( 2023-10-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	11.17
ATR14	$0.00300 (0.15%)

Tūris Koreliacija

Ilgas: -0.06 (neutral)

Trumpas: 0.00 (neutral)

Signal:(65.033) Neutral

Tianjin Pharmaceutical Da Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Tianjin Pharmaceutical Da Koreliacija - Valiuta/Žaliavos

0.35
( neutral )

0.30
( neutral )

0.00
( neutral )

-0.15
( neutral )

Tianjin Pharmaceutical Da Finansinės ataskaitos

Annual	2023
Pajamos:	$8.22B
Bruto pelnas:	$3.62B (44.01 %)
EPS:	$1.280

FY	2023
Pajamos:	$8.22B
Bruto pelnas:	$3.62B (44.01 %)
EPS:	$1.280

FY	2022
Pajamos:	$8.25B
Bruto pelnas:	$3.29B (39.93 %)
EPS:	$1.120

Financial Reports:

No articles found.

Tianjin Pharmaceutical Da

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.